WuXi STA, a subsidiary of WuXi AppTec, has received scores of 60+ with a Silver rating from EcoVadis, a provider of business sustainability ratings, for its three sites in China.
The scores were received for active pharmaceutical ingredients (API) R&D and manufacturing from the Changzhou site, and for formulation development and manufacturing from the Shanghai Waigaoqiao site and Wuxi city sites, respectively.
The sustainability audits were performed in November 2022 based on four aspects of business: environment, labour and human rights, ethics, and sustainability procurement.
EcoVadis provides benchmarks for rated companies in their industry to drive global supply chain sustainability and encourage industry-wide competence to achieve better global practice and continuous improvement.
WuXi AppTec’s efforts in business sustainability and social responsibility also resulted in the company’s first inclusion in the S&P Dow Jones Sustainability Emerging Markets Index in 2021 and an AA rating for a second consecutive year from Morgan Stanley Capital International 2022.
In addition, the company received a “Strong” management score by Sustainalytics this year, ranking in the top 2% in the global pharmaceutical industry.
